Dawaa Reference

chronic

Concern or Fear of Breast Cancer

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Breast Cancer Screening in the Average-Risk Patient - StatPearls - NCBI Bookshelf (NBK556050) - https://www.ncbi.nlm.nih.gov/books/NBK556050/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class GS93 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

A patient presenting with fear of breast cancer requires an empathetic clinical breast examination to exclude palpable masses, skin changes, or pathologic nipple discharge. Provide age-appropriate screening education (routine screening mammography starting at age 40 to 50 according to local guidelines) and reassure the patient if the physical examination is normal and risk factors are average. If high-risk features are present, such as strong family history of breast or ovarian cancer, refer to specialized genetics or breast clinics for formal risk assessment. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A patient presenting with fear of breast cancer requires an empathetic clinical breast examination to exclude palpable masses, skin changes, or pathologic nipple discharge. Provide age-appropriate screening education (routine screening mammography starting at age 40 to 50 according to local guidelines) and reassure the patient if the physical examination is normal and risk factors are average. If high-risk features are present, such as strong family history of breast or ovarian cancer, refer to specialized genetics or breast clinics for formal risk assessment.

Cautions
  • RED FLAG - Unilateral axillary lymphadenopathy: assess urgently and refer.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - A palpable lump or skin change found on examination moves this to breast lump/mass instead; a strong family history warrants referral for genetic counselling.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.